Patents by Inventor Herbert Stadler
Herbert Stadler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250020556Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: ApplicationFiled: October 1, 2024Publication date: January 16, 2025Applicant: Juno Therapeutics GmbHInventor: Herbert STADLER
-
Patent number: 12135265Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: GrantFiled: December 21, 2018Date of Patent: November 5, 2024Assignee: Juno Therapeutics GmbHInventor: Herbert Stadler
-
Publication number: 20240329039Abstract: Provided are affinity-based methods of isolating biological entities via a surface antigen from a sample with non-chromatographic and chromatographic methods being provided. Also provided is a dextran polymer, kits for use in the method of isolating a biological entity and an apparatus for performing the methods.Type: ApplicationFiled: March 19, 2024Publication date: October 3, 2024Inventor: Herbert STADLER
-
Patent number: 12066365Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: GrantFiled: December 21, 2018Date of Patent: August 20, 2024Assignee: Juno Therapeutics GmbHInventor: Herbert Stadler
-
Patent number: 11965882Abstract: Provided are affinity-based methods of isolating biological entities via a surface antigen from a sample with non-chromatographic and chromatographic methods being provided. Also provided is a dextran polymer, kits for use in the method of isolating a biological entity and an apparatus for performing the methods.Type: GrantFiled: February 1, 2021Date of Patent: April 23, 2024Assignee: CELL.COPEDIA GMBHInventor: Herbert Stadler
-
Publication number: 20230210895Abstract: Provided are novel biologically active blood fractions that can be used for the treatment of damaged epithelial surfaces and that are nanofilterable as well as corresponding compositions and eye drops and methods of their manufacture.Type: ApplicationFiled: August 3, 2021Publication date: July 6, 2023Inventors: Herbert STADLER, Stefan SCHNEIDER, Andrea JOCHHEIM-RICHTER, Ingeborg SILLABER
-
Publication number: 20230140446Abstract: Provided are affinity-based methods of isolating biological entities via a surface antigen from a sample with non-chromatographic and chromatographic methods being provided. Also provided is a dextran polymer, kits for use in the method of isolating a biological entity and an apparatus for performing the methods.Type: ApplicationFiled: February 1, 2021Publication date: May 4, 2023Inventor: Herbert STADLER
-
Patent number: 10369561Abstract: A first aspect of the invention relates to a syringe housing which can have the following elements: a syringe body which has a first open end and a second open end, a first channel being formed between the two ends; a first membrane which is arranged such that the membrane extends substantially perpendicularly to the longitudinal direction of the first channel over the cross-section thereof; a syringe body attachment which has a first open end and a second open end, a second channel being formed between the two ends; a second membrane which is arranged such that the membrane extends substantially perpendicularly to the longitudinal direction of the second channel over the cross-section thereof; wherein the second open end of the syringe body and the first open end of the syringe body attachment are designed so as to be connectable in a formfitting manner and thus form the syringe housing, the first channel and the second channel form a continuous channel in the connected state of the syringe housing, and theType: GrantFiled: December 10, 2015Date of Patent: August 6, 2019Assignee: Cell.Copedia GmbHInventors: Herbert Stadler, Wilhelm Gerdes, Sabine Przibilla
-
Publication number: 20190234844Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: ApplicationFiled: December 21, 2018Publication date: August 1, 2019Applicant: Juno Therapeutics GmbHInventor: Herbert STADLER
-
Publication number: 20190226951Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: ApplicationFiled: December 21, 2018Publication date: July 25, 2019Applicant: Juno Therapeutics GmbHInventor: Herbert STADLER
-
Patent number: 10228312Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: GrantFiled: February 25, 2013Date of Patent: March 12, 2019Assignee: Juno Therapeutics GmbHInventor: Herbert Stadler
-
Publication number: 20170361314Abstract: A first aspect of the invention relates to a syringe housing which can have the following elements: a syringe body which has a first open end and a second open end, a first channel being formed between the two ends; a first membrane which is arranged such that the membrane extends substantially perpendicularly to the longitudinal direction of the first channel over the cross-section thereof; a syringe body attachment which has a first open end and a second open end, a second channel being formed between the two ends; a second membrane which is arranged such that the membrane extends substantially perpendicularly to the longitudinal direction of the second channel over the cross-section thereof; wherein the second open end of the syringe body and the first open end of the syringe body attachment are designed so as to be connectable in a formfitting manner and thus form the syringe housing, the first channel and the second channel form a continuous channel in the connected state of the syringe housing, and theType: ApplicationFiled: December 10, 2015Publication date: December 21, 2017Inventors: Herbert Stadler, Wilhelm Gerdes, Sabine Przibilla
-
Publication number: 20150024411Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.Type: ApplicationFiled: February 25, 2013Publication date: January 22, 2015Inventor: Herbert Stadler
-
Patent number: 4783956Abstract: In a method and an apparatus for producing a yarn by means of friction spinning drums, a fiber sliver is transformed into a body of fibers and transferred to a first perforated friction spinning drum of such friction spinning drums. At this first perforated friction spinning drum, the fibers are entrained by a suction air stream, produced by a suction passage located in the first perforated friction spinning drum, and are then fed into a converging space formed by and between the friction spinning drums. In this converging space the fibers are twisted into a spun yarn. The spun yarn is withdrawn by withdrawal rollers located near end faces of the friction spinning drums. The suction air stream required for entraining or catching the fibers is limited by walls forming the suction passage. The advantage of this apparatus is that the fibers are mechanically guided over the whole length of their travel path, i.e. from the body of fibers to the twisted yarn. As a result, the fibers never swim freely.Type: GrantFiled: December 15, 1986Date of Patent: November 15, 1988Assignee: Rieter Machine Works LimitedInventor: Herbert Stadler